Introducing
Clinical AI That's Ready for the Real World
DorothAI™ is a governance platform that lets healthcare teams deploy and manage AI safely within their existing workflows.
- Built in safety and compliance
- Integrates with clinical workflows
- Clear audit trails for every decision
A Clinical Governance Engine
AI that can safely operate in clinical environments
AI that can safely operate in clinical environments
AI that can safely operate in clinical environments
DorothAI™ monitors patient safety risks in real-time providing alerts to prevent patient harm while maintaining full compliance.
Example Use Case
AI that can safely operate in clinical environments
AI that can safely operate in clinical environments
Starting with cardio-oncology safety during chemotherapy, we bridge the gap between static models and high-risk clinical workflows.
DorothAI™ improves outcomes for 100K+ patients annually receiving HER2-targeted therapy across major markets.
Clinical Workflow
Governed AI Output
Clinical Workflow
Deep integration into the patient’s oncology journey, capturing nuanced real world data.
Micro-Model™
Governed AI Output
Clinical Workflow
Task specific, highly specialised models designed for predictive accuracy in cardiotoxicity.
Governed AI Output
Governed AI Output
Governed AI Output
Auditable, printable results with built in human in the loop validation checkpoints.
Monitoring patient safety during cancer treatments
Hospitals & providers
Hospitals & providers
Hospitals & providers
Deploy AI safely across your organization while maintaining full clinical control:
- Reduced clinical liability
- Better patient outcomes
- Automated safety reporting
Academic centers
Hospitals & providers
Hospitals & providers
Built evidence with governed data and traceable models for clinical research:
- Validated data cohorts
- Replaceable model training
- Auditable research metrics
Pharma & industry
Hospitals & providers
Pharma & industry
Accelerate development with trusted outcomes and continue safety monitoring:
- Trusted clinical outcomes
- Post market surveillance
- Scalable safety protocols